Replimune (REPL) Change in Account Payables (2017 - 2025)
Replimune's (REPL) quarterly Change in Account Payables came in at -$730000.0 in Q4 2025, up 36.47% year-on-year from -$534929.8 in Q4 2024, and up 91.83% quarter-over-quarter from -$8.9 million in Q3 2025.
Replimune (REPL) Change in Account Payables (2017 - 2025) Analysis & Trends
Replimune has disclosed Change in Account Payables across 9 years of filings, most recently posting -$730000.0 for Q4 2025.
- Change in Account Payables for Q4 2025 came in at -$730000.0, up 36.47% year-over-year; the trailing twelve-month figure through Dec 2025 was -$654000.0 (down 119.17% YoY), and the FY2025 annual result was $9.9 million, up 455.8% from the prior year.
- Change in Account Payables came in at -$730000.0 for Q4 2025 at Replimune, up from -$8.9 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $7.5 million in Q3 2024 to a low of -$8.9 million in Q3 2025.
- The 5-year median for Change in Account Payables is -$136000.0 (2022), against an average of $216900.0.
- Across the five-year window, Change in Account Payables sank 476.92% in 2022 and jumped 3604.23% in 2024, its largest moves.
- Replimune's Change in Account Payables stood at $443000.0 in 2021, then sank by 176.98% to -$341000.0 in 2022, then slumped by 39.59% to -$476000.0 in 2023, then sank by 141.39% to -$1.1 million in 2024, then surged by 36.47% to -$730000.0 in 2025.
- The last three Change in Account Payables figures came in at -$730000.0 (Q4 2025), -$8.9 million (Q3 2025), and $3.8 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -9.42 Mn |
| 10 | Replimune | 780.01 Mn | 510.88 Mn | - | -730,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -730,000.00 |
| Dec 31, 2025 | -730,000.00 |
| Sep 30, 2025 | -8.93 Mn |
| Sep 30, 2025 | -8.93 Mn |
| Jun 30, 2025 | 3.77 Mn |
| Jun 30, 2025 | 3.77 Mn |
| Mar 31, 2025 | 5.24 Mn |
| Mar 31, 2025 | 5.24 Mn |
| Dec 31, 2024 | -1.15 Mn |
| Dec 31, 2024 | -1.15 Mn |
| Sep 30, 2024 | 7.46 Mn |
| Sep 30, 2024 | 7.46 Mn |
| Jun 30, 2024 | -1.62 Mn |
| Jun 30, 2024 | -1.62 Mn |
| Mar 31, 2024 | -1.29 Mn |
| Mar 31, 2024 | -1.29 Mn |
| Dec 31, 2023 | -476,000.00 |
| Dec 31, 2023 | -476,000.00 |
| Sep 30, 2023 | -213,000.00 |
| Sep 30, 2023 | -213,000.00 |